Bharat Biotech to get EUA from WHO for its indigenous corona vaccine

New Delhi: The wait for World Health Organization (WHO) approval for the corona vaccine Covaxin manufactured by Bharat Biotech is now coming to an end. Hyderabad-based Bharat Biotech is waiting for the much-awaited Emergency Use Authorization (EUA) from WHO for its indigenous corona vaccine 'Covaxin.' However, WHO's guidance document shows that the final approval for Covaxin is likely to be completed by October.

The Strategic Advisory Group of Experts (SAGE) is scheduled to meet in October to approve WHO for the use of emergency. The meeting is scheduled for October 5 and it is expected that the Bharat Biotech vaccine may be flagged off by the WHO. The Union Ministry of Health and Family Welfare had indicated that the global health body may soon give the green signal to the vaccine to use emergency.

According to media reports, Dr Bharti Praveen Pawar, Union Minister of State in the Ministry of Health said that ''At present, a process is underway to submit documents for approval by the vaccine manufacturer. Covaxin is expected to receive emergency use authorization from WHO soon.''

Chhattisgarh: More than 12 MLAs reach Delhi amid crisis in Punjab Congress

India will send 3 member team to attend PAK's anti-terror exercise

Covid Roundup: India records 23,529 new cases, 311 deaths

- Sponsored Advert -

Most Popular

- Sponsored Advert -